Thorkil Christensen

Former Chief Financial Officer at Novo Holdings A/S

Thorkil Christensen

Thorkil Christensen

Former Chief Financial Officer at Novo Holdings A/S

Overview
Career Highlights

Novo Principal Investments
Novo Holding A/S
Novo Ventures

RelSci Relationships

314

Number of Boards

8

Birthday

08/24/1947

Age

72

Relationships
RelSci Relationships are individuals Thorkil Christensen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director, Principal Investments at Novo Holding A/S

Relationship likelihood: Strong

Former Chief Executive Officer at Novo Holding A/S

Relationship likelihood: Strong

Advisor at VF Venture

Relationship likelihood: Strong

Managing Partner NOVO Ventures at Novo Holding A/S

Relationship likelihood: Strong

Director & Professor at Danish National Research Foundation

Relationship likelihood: Strong

Executive Vice President & Chief Science Officer (CSO) at Novo Nordisk A/S

Relationship likelihood: Strong

President & Chief Executive Officer at Novozymes A/S

Relationship likelihood: Strong

Managing Director, Financial Investments at Novo Holding A/S

Relationship likelihood: Strong

Senior Partner NOVO Ventures at Novo Holding A/S

Relationship likelihood: Strong

Asset Director Large Investments at Novo Holding A/S

Relationship likelihood: Strong

Paths to Thorkil Christensen
Potential Connections via
Relationship Science
You
Thorkil Christensen
Former Chief Financial Officer at Novo Holdings A/S
Education
MS Biochemistry

For almost two centuries DTU, Technical University of Denmark, has been dedicated to fulfilling the vision of H.C. Ørsted – the father of electromagnetism – who founded the university in 1829 to develop and create value using the natural sciences and the technical sciences to benefit society. Today, DTU is ranked as one of the foremost technical universities in Europe, continues to set new records in the number of publications, and persistently increase and develop our partnerships with industry, and assignments accomplished by DTU’s public sector consultancy.

MBA Finance

Copenhagen Business School, also known as CBS, is situated in Copenhagen, Denmark. CBS was established in 1917 by Danish Society for the Advancement of Business Education and Research(FUHU), however, it wasn't until 1920 that accounting became the first full study programme at CBS. Today CBS has more than 20,000 students, 13,000 employees and offers a wide range of undergraduate and graduate programmes within business all with an interdisciplinary and international focus. CBS' campus is located in the district of Frederiksberg and centers on CBS' main campus Solbjerg Plads (finished in 2000). Since the Danish Universities Act of 2003 CBS has had a Board of Directors with an external majority. The Board of Directors appoints the President of CBS, who is currently Per Holten-Andersen.

Career History
Chief Financial Officer
2003 - 2015

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation's assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

Chief Executive Officer China
2000 - 2003

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Chief Executive Officer
Prior

Part of Novo Nordisk Fonden, Novo Nordisk China is a company headquartered in Beijing, China, that manufactures and supplies medical products.

Boards & Committees
Member, Board of Directors
2017 - Current

A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems, rare conditions, long-term diseases and global pandemic threats.

Director
2009 - Prior

BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN.

Director
Prior

Jørgen Kruuse A/S manufactures and supplies veterinary products needed in the treatment and care of animals with worldwide distribution. Its brands include KRUUSE, BUSTER, KRUTEX, VALUELINE, EQUIVET and BOVIVET. The company was founded in 1939 and is headquartered in Langeskov, Denmark.

Board Member
Current

With over 40,000 students and more than 9,000 employees, the University of Copenhagen is the largest institution of research and education in Denmark. The purpose of the University – to quote the University Statute – is to ’conduct research and provide further education to the highest academic level’.

Member, Board of Directors
Current
Member, Advisory Board
Current

Roskilde University was formed under the Act of Copenhagen University's Siting and University Centres of 1970.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Thorkil Christensen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Thorkil Christensen's profile does not indicate a business or promotional relationship of any kind between RelSci and Thorkil Christensen.